48.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$49.86
Aprire:
$47
Volume 24 ore:
36.56M
Relative Volume:
1.75
Capitalizzazione di mercato:
$69.81B
Reddito:
$20.62B
Utile/perdita netta:
$3.56B
Rapporto P/E:
20.20
EPS:
2.3847
Flusso di cassa netto:
$3.48B
1 W Prestazione:
-7.38%
1M Prestazione:
+8.86%
6M Prestazione:
-36.41%
1 anno Prestazione:
-54.72%
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
48.17 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
ABT
Abbott Laboratories
|
114.10 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
329.67 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.02 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
EW
Edwards Lifesciences Corp
|
90.78 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-30 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific stock holds steady as institutional buyers build positions - Ad-hoc-news.de
Boston Scientific (NYSE:BSX) Gains Focus After Healthcare Shift - Kalkine Media
BSX|Boston Scientific Corp|Price:49.740|Chg%:+0.370 - TradingKey
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Edmond DE Rothschild Holding S.A. Acquires Shares of 875,810 Boston Scientific Corporation $BSX - MarketBeat
A Look at Boston Scientific Corp (BSX) After 3.0% Gain -- GF Val - GuruFocus
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific stock trades around $50 as Q2 2026 margins and earnings expand - AD HOC NEWS
Great Lakes Advisors LLC Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific stock holds in the low $51 range as Q2 2026 margins and EPS beat guidance - AD HOC NEWS
Boston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks - AboutLawsuits.com
Mitsubishi UFJ Asset Management Co. Ltd. Buys New Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp (BSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Boston Scientific (BSX) Faces Growth Concerns in Key Medical Device Franchises - Yahoo Finance
Boston Scientific stock extends 7-day rebound as Q2 2026 margins expand - AD HOC NEWS
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Trivium Point Advisory LLC Invests $1.48 Million in Boston Scientific Corporation $BSX - MarketBeat
S&CO Inc. Buys Shares of 169,791 Boston Scientific Corporation $BSX - MarketBeat
AAFMAA Wealth Management & Trust LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Mill Capital Management LLC Invests $9.85 Million in Boston Scientific Corporation $BSX - MarketBeat
Congress Large Cap Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX), What Is Behind The Latest Investor Attention? - finance.yahoo.com
Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance? - Yahoo Finance
Fidelity Blue Chip Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Is Boston Scientific (BSX) Still Undervalued After A 50% Fall? - Yahoo Finance
Brazil CADE reviews Boston Scientific’s acquisition of Penumbra - MLex
Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses - Yahoo Finance
Union Bancaire Privee UBP SA Sells 173,105 Shares of Boston Scientific Corporation $BSX - MarketBeat
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance
Here’s What Hurt Boston Scientific Corporation (BSX) in Q2 - Yahoo Finance
Boston Scientific Corporation $BSX Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Security National Bank Grows Holdings in Boston Scientific Corporation $BSX - MarketBeat
QRG Capital Management Inc. Buys 198,951 Shares of Boston Scientific Corporation $BSX - MarketBeat
NewEdge Advisors LLC Sells 27,583 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Fisher Funds Management LTD - MarketBeat
Brookstone Capital Management Sells 233,448 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific's CEO Bought $9M of His Own Stock - Quiver Quantitative
Boston Scientific (BSX) SVP Emily Woodworth adds 2,930 shares in 401(k) rebalance - Stock Titan
Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentals - ChartMill
Northside Capital Management LLC Purchases 49,189 Shares of Boston Scientific Corporation $BSX - MarketBeat
MiRus founder builds medtech firm worth billions after quest to save others from fate of his mentorAtlanta Business Chronicle - The Business Journals
Boston Scientific Corporation $BSX Shares Sold by E. Ohman J or Asset Management AB - MarketBeat
Boston Scientific (BSX) CFO adds 9,908 shares through discretionary 401(k) rebalancing - Stock Titan
Handelsbanken Fonder AB Sells 1,002,628 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Receives Average Recommendation of "Moderate Buy" from Brokerages - marketbeat.com
Boston Scientific: The $5.4 Billion Quarter Tells Me The Sell-Off Is Overdone (NYSE:BSX) - Seeking Alpha
Fidelity Series Blue Chip Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Stock Is Priced As If WATCHMAN Were The Whole Company - Yahoo Finance
Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026? - The Motley Fool
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):